Geneva team finds protein blocks antibiotic entry in bacteria
Researchers at the University of Geneva discovered a bacterial protein that immediately blocks antibiotic channels to prevent drug entry.

New defense mechanism found
A team led by Karl Perron at the University of Geneva studied Pseudomonas aeruginosa bacteria. They found the pathogen uses a protein called PtrA to stop imipenem from entering cells. This antibiotic is reserved for critical cases where other treatments fail. The bacterium reduces its production of OprD porins when exposed to copper and zinc. However, PtrA blocks the existing channels before those porins disappear completely.
Two stage resistance system
Verena Ducret explained that PtrA inserts itself into protein complexes where OprD sits. This action blocks the entrance to the antibiotic channel immediately upon metal exposure. According to a study appearing in the Proceedings of the National Academy of Sciences, this phenomenon is termed adaptive impermeability. First an immediate response occurs via PtrA blocking current porins. Then a lasting response follows by reducing new porin production over time.
Implications for treatment
This discovery suggests part of resistance escapes methods that measure only porin amounts. Current tests might miss this immediate defense because they look for mutations or missing channels. Scientists now ask if other pathogenic bacteria possess similar proteins in their envelopes. Disabling these strategies could one day restore full efficacy to last-resort antibiotics. The findings open new avenues for counteracting antibiotic resistance mechanisms.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.